blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1116791

EP1116791 - NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.09.2009
Database last updated on 03.10.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Green Peptide Co., Ltd.
10-4, Toori-machi, Kurume-shi
Fukuoka 830-0018 / JP
[2008/46]
Former [2008/44]For all designated states
Itoh, Kyogo
2-25-9, Keyaki-dai, Kiyama-cho Miyaki-gun
Saga 841-0205 / JP
Former [2006/02]For all designated states
Dainippon Sumitomo Pharma Co., Ltd.
6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi
Osaka-fu / JP
For all designated states
Itoh, Kyogo
2-25-9, Keyaki-dai, Kiyama-cho
Miyaki-gun, Saga 841-0205 / JP
Former [2001/29]For all designated states
Sumitomo Pharmaceuticals Company, Limited
2-8, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka 541-8510 / JP
For all designated states
Itoh, Kyogo
2-25-9, Keyaki-dai, Kiyama-cho
Miyaki-gun, Saga 841-0205 / JP
Inventor(s)01 / ITOH, Kyogo
2-25-9, Keyaki-dai, Kiyama-cho
Miyaki-gun, Saga 841-0205 / JP
02 / NAKAO, Masanobu
277-1, Oaza Ohashi
Okawa-shi, Fukuoka 831-0021 / JP
 [2001/29]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2001/29]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date99940508.727.08.1999
[2001/29]
WO1999JP04622
Priority number, dateJP1998024266028.08.1998         Original published format: JP 24266098
[2001/29]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0012701
Date:09.03.2000
Language:EN
[2000/10]
Type: A1 Application with search report 
No.:EP1116791
Date:18.07.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 09.03.2000 takes the place of the publication of the European patent application.
[2001/29]
Type: B1 Patent specification 
No.:EP1116791
Date:29.10.2008
Language:EN
[2008/44]
Search report(s)International search report - published on:JP09.03.2000
(Supplementary) European search report - dispatched on:EP28.11.2001
ClassificationIPC:C12N15/12, C12N5/10, C12P21/02, C07K14/47, C07K16/30, A61K31/70, A61K48/00, A61K38/17, A61K39/00, A61K35/12
[2001/29]
CPC:
C07K14/4748 (EP,US); C12N15/11 (KR); A61P35/00 (EP);
A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/29]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:NEUES TUMOR-ANTIGEN-PROTEIN SART-3 UND TUMOR-ANTIGEN-PEPTID DAVON[2001/29]
English:NOVEL TUMOR ANTIGEN PROTEIN SART-3 AND TUMOR ANTIGEN PEPTIDE THEREOF[2001/29]
French:NOUVELLE PROTEINE D'ANTIGENE TUMORAL SART-3 ET PEPTIDE D'ANTIGENE TUMORAL DE CELLE-CI[2001/29]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase28.03.2001Translation filed 
28.03.2001National basic fee paid 
28.03.2001Search fee paid 
28.03.2001Designation fee(s) paid 
28.03.2001Examination fee paid 
Examination procedure24.01.2000Request for preliminary examination filed
International Preliminary Examining Authority: JP
28.03.2001Amendment by applicant (claims and/or description)
28.03.2001Examination requested  [2001/29]
24.11.2004Despatch of a communication from the examining division (Time limit: M06)
06.06.2005Reply to a communication from the examining division
10.01.2006Despatch of a communication from the examining division (Time limit: M04)
09.05.2006Reply to a communication from the examining division
15.09.2006Despatch of a communication from the examining division (Time limit: M06)
19.03.2007Reply to a communication from the examining division
08.10.2007Despatch of a communication from the examining division (Time limit: M06)
17.03.2008Reply to a communication from the examining division
29.04.2008Communication of intention to grant the patent
09.09.2008Fee for grant paid
09.09.2008Fee for publishing/printing paid
Opposition(s)30.07.2009No opposition filed within time limit [2009/41]
Fees paidRenewal fee
30.08.2001Renewal fee patent year 03
30.08.2002Renewal fee patent year 04
01.09.2003Renewal fee patent year 05
31.08.2004Renewal fee patent year 06
31.08.2005Renewal fee patent year 07
31.08.2006Renewal fee patent year 08
31.08.2007Renewal fee patent year 09
31.03.2008Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.10.2008
BE29.10.2008
CY29.10.2008
DK29.10.2008
FI29.10.2008
NL29.10.2008
SE29.01.2009
GR30.01.2009
PT30.03.2009
[2011/44]
Former [2011/25]AT29.10.2008
BE29.10.2008
DK29.10.2008
FI29.10.2008
NL29.10.2008
SE29.01.2009
GR30.01.2009
PT30.03.2009
Former [2010/06]AT29.10.2008
BE29.10.2008
DK29.10.2008
FI29.10.2008
NL29.10.2008
SE29.01.2009
PT30.03.2009
Former [2009/32]AT29.10.2008
BE29.10.2008
FI29.10.2008
NL29.10.2008
PT30.03.2009
Former [2009/30]AT29.10.2008
FI29.10.2008
NL29.10.2008
PT30.03.2009
Documents cited:Search[E]EP1033401  (GENSET SA [FR]) [E] 1 * page 5934 *;
 [E]WO0055174  (HUMAN GENOME SCIENCES INC [US], et al) [E] 1-7,16-19,24,25 * Seq. ID 1496; 99% identitty in 569 aa overlap (395-963:10-578); page 1320 - page 1322 *;
 [X]  - OHARA O. ET AL., "Human mRNA for KIA0156 gene, complete cds.", EMBL, (19950825), XP002182056 [X] 1,5,16,17 * 100% identity over 963 aas *
 [X]  - TOH U. ET AL., "HLA class I-restricted and tumor-specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancer", CELLULAR IMMUNOLOGY, vol. 177, pages 137 - 143, XP002182054 [X] 20-23 * the whole document *

DOI:   http://dx.doi.org/10.1006/cimm.1997.1105
    [ ] - DUMAS ET AL., "5' ESTs", EMBL, XP002182855 [ ] * Human secreted protein 5934 90% identity in 93 aa overlap (1-93:1-93) *
 [PX]  - YANG D. ET AL., "Identification of a gene for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients", CANCER RESEARCH, (19990815), vol. 59, pages 4056 - 4063, XP002182055 [PX] 1-27 * the whole document *
International search[A]  - SHIGEKI SHICHIJO ET AL., "A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes", J. EXP. MED., (19980202), vol. 187, no. 3, pages 277 - 288, XP002932468
 [A]  - RUMI GOHARA, "Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Coiono Cancer", JPN. J. CANCER RES., (199702), vol. 88, no. 2, pages 198 - 204, XP002932469
 [A]  - TAKAHIRO NAGASE, "Prediction of the Coding Sequences of Unidentified Human Genes. IV. The Coding Sequences of 40 New Genes (KIAA0121-KIAA0160) Deduced by Analysis of cDNA Clones from Human Cell Line KG-1", J. CLIN. INVEST., (199508), vol. 2, no. 4, pages 167 - 174, XP002932470
 [A]  - P. YOTNDA, "Cytotoxic T Cell Response against the Chimeric ETV6-AML1 Protein in Childhood Acute Lymphoblastic Leukemia", J. CLIN. INVEST., (199807), vol. 102, no. 2, pages 455 - 462, XP002932471
 [A]  - TAKENORI TAKAHASHI, "Recognition of gp43 Tumor-Associated Antigen Peptide by both HLA-A2 Restricted CTL Lines and Antibodies from Melanoma Patients", CELLULAR IMMUNOLOGY, (19970615), vol. 178, no. 2, pages 162 - 171, XP002932472
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.